Fate Therapeutics Inc (NASDAQ:FATE)

18.20
Delayed Data
As of Sep 20
 +0.34 / +1.90%
Today’s Change
11.00
Today|||52-Week Range
22.82
+41.86%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close17.86
Today’s open17.85
Day’s range17.76 - 18.52
Volume1,603,837
Average volume (3 months)806,185
Market cap$1.2B
Data as of 3:59pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)-16.19%
Earnings growth (this year)-20.01%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.44%
P/E ratioNM
Price/Sales152.11
Price/Book7.24

Competitors

 Today’s
change
Today’s
% change
ALECAlector Inc+1.42+7.68%
MNTAMomenta Pharmaceutic...+0.06+0.45%
RDUSRadius Health Inc-0.39-1.35%
RGNXRegenxbio Inc+0.48+1.22%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateNovember 14, 2019
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$4.7M
Annual profit (last year)-$66.6M
Net profit margin-1,405.02%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
J. Scott Wolchko
Chief Scientific Officer
Daniel D. Shoemaker
Corporate headquarters
San Diego, California

Forecasts